The formulation and delivery of drugs have played a crucial role in the development and commercialisation of pharmaceutical products during the last decade and none of the most commercially successful drugs have escaped the attention of companies wishing to improve convenience of their delivery to the patient. Drug delivery will play an increasingly important role in the next decade as more macromolecules including proteins, peptides and oligonucleotides find their way to the market.
Brief Scope of this report
Identifies new opportunities for drug delivery companies and provides a summary of the developments associated with new delivery systems for the top selling drugs and macromolecules.
Reviews developments in novel delivery of top-selling polypeptides and proteins, macromolecules, which have also traditionally presented significant problems in terms of delivery to the patient.With increased current interest in alternative systems to oral and parenteral drug delivery, the report describes novel systems used for inhaled (pulmonary) and nasal delivery of drugs as well novel oral systems, transdermal and depot parenteral systems.
Profiles of companies specialising in drug delivery have been included, which focus on their technology and how it is being applied to improve delivery of small and macromolecules.
(0 items)
